Meeting
2012 ASCO Annual Meeting
Impact of exogenous female hormone use (EHU) on breast cancer (BC) recurrence as assessed by the 21-gene assay (Oncotype DX).
Authors
Wendy M. Ledesma
University of Wisconsin Carbone Cancer Center, Madison, WI
Wendy M. Ledesma , Adedayo A. Onitilo , Chong Zhang , KyungMann Kim , Molly Andreason , John A. Charlson , Kimberly Ridolfi , Jessica Marie Engel , Kari Braun Wisinski , Robert Millholland , James T Dean , Amye Tevaarwerk
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 30, 2012 (suppl; abstr 563)
DOI
10.1200/jco.2012.30.15_suppl.563
Abstract #
563
Poster Bd #
4F
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
First Author: Saumya Umashankar
Poster
2017 ASCO Annual Meeting
Prognostic significance of tumor subtypes in women with breast cancer according to stage: A population-based study.
First Author: Jose Pablo Leone
Poster
2013 Breast Cancer Symposium
Significance of HER2/neu overexpression in pure ductal carcinoma in situ: A clinicopathologic study with long-term follow-up.
First Author: Zeina Al-Mansour
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong